We have a broad portfolio of medicines prescribed to patients in hospitals, diverse in terms of therapeutical groups and medical indications.
Our active portfolio and pipeline contain products from all 14 ATC groups, including both medicines and vaccines.
„ We aim to become a regional leader with diversified portfolio of registered hospital medicines. Our door is always open for new partnerships and product units. Beside generic and selective innovative medicines, we are particularly interested in expanding our portfolio with biosimilars. “
Doris Milosevic, Hospital Medicines Division Leader